A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast
Year: 2026
Type: article
Study design: Case Report
Abstract: Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. Figure S1: Clinical course of the present case. Erythema and tense blisters improved with minocycline, nicotinic acid, apremilast and topical corticosteroids. The rash relapsed as apremilast was discontinued and improved with the resumption of apremilast. BPDAI: bullous pemphigoid disease area index, BP180 Ab: anti-BP180NC16a antibody levels. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: The Journal of Dermatology
Institution: Yokohama City University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7129106105